Creative Medical Technology Holdings (CELZ) Other Working Capital Changes (2022 - 2025)
Creative Medical Technology Holdings' (CELZ) quarterly Other Working Capital Changes came in at -$34572.0 in Q2 2026, up 34.22% year-over-year from -$25757.7 in Q2 2025, and down 2.37% quarter-over-quarter from -$33772.0 in Q1 2026.
Analysis
Creative Medical Technology Holdings (CELZ) Other Working Capital Changes (2022 - 2025) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Other Working Capital Changes for 3 consecutive years, with -$34572.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Working Capital Changes rose 34.22% year-over-year to -$34572.0 in Q2 2026; TTM through Jun 2026 was -$173458.0, a 331.98% decrease from a year earlier, with the FY2025 full-year figure at -$53903.0, up 36.24% from the prior year.
- Other Working Capital Changes was -$52557.0 for Q3 2025 at Creative Medical Technology Holdings, roughly flat from -$52557.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $92214.0 in Q1 2023 and troughed at -$86682.0 in Q1 2024.
- A 4-year average of -$8242.5 and a median of -$52557.0 in 2025 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 35.74% in 2026, down 34.22% in 2026.
- Over 4 years, Other Working Capital Changes stood at -$64960.0 in 2022, then soared by 241.96% to $92214.0 in 2023, then sank by 166.67% to -$61478.0 in 2024, then advanced by 14.51% to -$52557.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$52557.0 (Q3 2025), -$52557.0 (Q2 2025), and -$52557.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | Creative Medical Technology Holdings | 1.48 Mn | 1.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -52,557.00 |
| Sep 30, 2025 | -52,557.00 |
| Jun 30, 2025 | -52,557.00 |
| Jun 30, 2025 | -52,557.00 |
| Mar 31, 2025 | -52,557.00 |
| Mar 31, 2025 | -52,557.00 |
| Sep 30, 2024 | -61,478.00 |
| Sep 30, 2024 | -61,478.00 |
| Jun 30, 2024 | -61,478.00 |
| Jun 30, 2024 | -61,478.00 |
| Mar 31, 2024 | -86,682.00 |
| Mar 31, 2024 | -86,682.00 |
| Sep 30, 2023 | 92,214.00 |
| Sep 30, 2023 | 92,214.00 |
| Jun 30, 2023 | 92,214.00 |
| Jun 30, 2023 | 92,214.00 |
| Mar 31, 2023 | 92,214.00 |
| Mar 31, 2023 | 92,214.00 |
| Sep 30, 2022 | -64,960.00 |
| Sep 30, 2022 | -64,960.00 |